Combination of lenalidomide with R-CHOP (R2CHOP) as an initial therapy for aggressive B-cell lymphomas: A phase I/II study.
G. S. Nowakowski
No relevant relationships to disclose
C. B. Reeder
Research Funding - Celgene
B. LaPlant
No relevant relationships to disclose
T. M. Habermann
No relevant relationships to disclose
C. Rivera
No relevant relationships to disclose
W. R. Macon
No relevant relationships to disclose
D. J. Inwards
No relevant relationships to disclose
I. N. M. Micallef
No relevant relationships to disclose
P. B. Johnston
No relevant relationships to disclose
L. F. Porrata
No relevant relationships to disclose
S. M. Ansell
No relevant relationships to disclose
T. E. Witzig
No relevant relationships to disclose